|Bid||25.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||51.78 - 52.30|
|52 Week Range||27.79 - 57.55|
|PE Ratio (TTM)||43.64|
|Earnings Date||Jul 31, 2018 - Aug 6, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||57.56|
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, will showcase its advanced technologies at the Scoliosis Research Society’s (SRS) 25th Annual International Meeting on Advanced Spine Techniques (IMAST) being held July 11-14, 2018, in Los Angeles, California. The company will also highlight its robotics platform technology through an industry workshop at IMAST, ExcelsiusGPS® First Clinical Experiences, featuring its revolutionary robotic guidance and navigation system on July 13 from 12:00-1:00 pm led by Dr. Jeffrey A. Goldstein, Chief of Spine Service for Education and Director of the Spine Fellowship at NYU Langone Orthopedic Hospital.
LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want a free Stock Review on NSPR sign up now at www.wallstequities.com/registration. Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Medical Appliances & Equipment stocks: Globus Medical Inc. (NYSE: GMED), InspireMD Inc. (NYSE AMER: NSPR), Lantheus Holdings Inc. (NASDAQ: LNTH), and LivaNova PLC (NASDAQ: LIVN).
“This is an exciting time for Globus Trauma as we continue to execute our product launch strategy and build a comprehensive Trauma product portfolio,” said Barclay Davis, Vice President, Orthopedic Trauma.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, announced today a new clinical milestone with the successful implantation of over 3,000 screws using ExcelsiusGPS®, the company’s revolutionary robotic guidance and navigation system. Since the launch of ExcelsiusGPS® in late 2017, orthopedic and neurosurgeons have used the system with three compatible imaging modalities (preoperative CT, intraoperative CT, and fluoroscopic imaging) across a variety of spine surgery procedures to minimize radiation exposure, streamline workflow, and assist in screw placement. A recent white paper comparing robotic-assisted versus conventional screw placement demonstrates some of the benefits of this technology. “Having completed installations and surgeon training programs through the first half of 2018, we see surgeons using this technology in open and minimally invasive spine procedures including posterior cervical fusion, sacroiliac joint fusion, and thoracolumbar fusion with posterior and single position lateral approaches,” said Chief Executive Officer Dave Demski.
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to begin learning the link betweenRead More...
Globus Medical (GMED) has missed three consensus revenue estimates and one consensus EPS estimate in the last 20 quarters. It has a dividend yield of 0% compared to the sector and the S&P 500 at 0.9% and 2.3%, respectively. What contributed to GMED’s valuations?
Biotech stocks are also capitalizing on AI’s potential to deliver revolutionary drugs and speed up drug discovery. “I believe that AI is a sleeping giant for healthcare in general,” Eric Horvitz, director of Microsoft Research Labs, said earlier this year.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of patients with advanced stage tumors of the thoracolumbar spine. CREO® fenestrated screws, when augmented with the company’s FORTRESS™ radiopaque bone cement, are designed to restore the structural integrity of the spine at vertebral levels affected by metastatic bone disease.
Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.
WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.
Spine stocks were steadied with supportive coverage from the Street this week. The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED ...
AUDUBON, Pa., May 21, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’ s emerging ...
When you think of artificial intelligence (AI), you might not immediately think of the healthcare sector. Here we take a closer look at three intriguing stocks using AI to forge new advances in treating and tackling disease. To pinpoint these three stocks, we used TipRanks' data to scan for 'Strong Buy' stocks in the healthcare sector.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the results of the study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up” published in the Journal of Spine Surgery, supporting benefits of Globus’ expandable lateral spacers. The study co-authored by Joseph O’Brien, MD, orthopedic surgeon at Washington Spine and Scoliosis Institute and Dr. Richard Frisch, orthopedic surgeon at Southeastern Spine Institute, compared clinical and radiographic outcomes of fifty-six patients who underwent minimally invasive lateral lumber interbody fusion (LLIF) for symptomatic degenerative disc disease. Radiographic evidence confirmed solid fusion was achieved in 100% of levels treated in both groups, however, significant differences in the rate of implant subsidence were observed.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly developed Partnership Program as that organization’s first corporate Alliance Partner. SOLAS® is a non-profit organization that strives to shape the future of lateral access spine surgery through collaboration among members, exchange of ideas, and the promotion of new techniques that benefit patients, physicians and hospitals. This sponsorship demonstrates Globus Medical’s commitment to supporting key educational and research initiatives important to advancing lateral access surgery. “Globus Medical recognizes that SOLAS® is the largest surgeon organization focused primarily on advancing lateral access surgery through peer-to-peer interaction and clinical research”, said Andrew Iott, Senior Vice President Global Product Development.
The new ExcelsiusGPS robotics and navigation system generates big sales growth for the medical-device company in the first quarter.
The Audubon, Pennsylvania-based company said it had net income of 39 cents per share. Earnings, adjusted for one-time gains and costs, were 41 cents per share. The results topped Wall Street expectations. ...
AUDUBON, Pa., May 02, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018.. Worldwide sales were $174.4 ...
Along with Abiomed and Inogen, spinal implant manufacturer Globus Medical is among five top medical stocks with a 99 Composite Rating.
NEW YORK, April 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
AUDUBON, Penn., April 17, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after the market close ...